 A CLINICAL STUDY TO EVALUATE THE PHARMACOKINETICS AND THE ABSOLUTE BIOAVAILABILITY OF SRT2104 GIVEN AS A 250MG ORAL SUSPENSION AND INTRAVENOUS MICRODOSE OF 100 ΜG CARBON-14 RADIO-LABELED SRT2104 IN HEALTHY MALE SUBJECTS: 